Icatibant Injection, Solution
Product Images NDC 55150-351

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Icatibant (NDC 55150-351). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 2 Time To 50% Reduction From Baseline In 3-item Vas Score (Icatibant Fig1)

FDA Label Image

Figure I (Icatibant Fig10)

FDA Label Image

Figure J (Icatibant Fig11)

FDA Label Image

Figure K (Icatibant Fig12)

FDA Label Image

Figure L (Icatibant Fig13)

FDA Label Image

Figure M (Icatibant Fig14)

FDA Label Image

Figure N (Icatibant Fig15)

FDA Label Image

Figure O (Icatibant Fig16)

FDA Label Image

Package Label-principal Display Panel-30 mg Per 3 mL (10 mg/ml) (Syrine Label)

Package Label-principal Display Panel-30 mg Per 3 mL (10 mg/ml) (Syrine Label)
Icatibant is a medication available in the form of an injection. Each injection contains 30 mg of the active ingredient per 3 mL, with a concentration of 10 mg/mL. This injection is intended for subcutaneous use only. The medication comes in a single-dose prefilled syringe with a capacity of 3 mL. It is manufactured in India for Eugia US LLC, based in E. Windsor, NJ 08520. The code displayed is TS/DRUGS/13/2010.*
FDA Label Image

Package Label-principal Display Panel-30 mg Per 3 mL (10 mg/ml) (Syringe Carton (1 Syringe))

Package Label-principal Display Panel-30 mg Per 3 mL (10 mg/ml) (Syringe Carton (1 Syringe))
This text appears to be from the packaging of a medication called Carlon. The medication is contained in a single-dose, prefilled syringe with a protective cap. It is indicated for subcutaneous use and each syringe delivers 30 mg of icatibant. The inactive ingredients include sodium chloride, glacial acetic acid, sodium hydroxide, and water for injection. The medication should be stored between 2° to 25°C and should not be frozen. The package insert contains full prescribing information, dosage, and administration instructions. The medication does not contain preservatives and the plunger rubber stopper is not made with natural rubber latex.*
FDA Label Image

Package Label-principal Display Panel-30 mg Per 3 mL (10 mg/ml) (Syringe-Carton (3 Syringes))

FDA Label Image

Figure A (Icatibant Fig2)

Figure A (Icatibant Fig2)
This is a description for a pre-filled syringe with a protective cap over the syringe tip. It may come with an alcohol wipe, but the wipe is not included in the carton.*
FDA Label Image

Figure B (Icatibant Fig3)

FDA Label Image

Figure C (Icatibant Fig4)

FDA Label Image

Figure D (Icatibant Fig5)

FDA Label Image

Figure E (Icatibant Fig6)

FDA Label Image

Figure F (Icatibant Fig7)

FDA Label Image

Figure G (Icatibant Fig8)

FDA Label Image

Figure H (Icatibant Fig9)

FDA Label Image

Chemical Structure (Icatibant Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.